The use of adenosine compounds for the preparation in the treatment of ischaemia
ZA9201168B
Use of s-adenosyl-l-methionine in the treatment of intrahepatic cholestasis determined by total parenteral nutrition
US5223500A
Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate
ZA9108355B
Pharmaceutical compositions active in the therapy of neurological affections in aids patients,containing as an active principle at least one compound selected from the group consisting of s-adenosyl-l-methionine salt,5-methyl-tetrahydrofolic acid,5-formyltetrahydrofolic acid
EP0388827A1
Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions
AU5127290A
Use of 5'deoxy-5'methylthioadenosine, s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions, and the pharmaceutical compositions concerned
EP0387757A2
Use of 5'-deoxy-5'methylthioadenosine, S-adenosylmethionine and their salts in the preparation of pharmaceutical compositions favouring hair growth in subjects suffering from baldness
EP0387756A1
Use of 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions
EP0382019A1
Use of 5-methyltetrahydrofolic acid, of 5-formyl-tetrahydrofolic acid and of their pharmaceutically acceptable salts for the preparation of controlled release pharmaceutical compositions suitable for the use in the therapy of depressive disturbances, and pharmaceutical compositions thus prepared
EP0352609A1
Use of adenosine derivatives in preparing pharmaceutical compositions possessing immunostimulant activity
EP0290819A2
Pteridines suitable for the preparation of pharmaceutical compositions with antiamnesic activity
EP0207437A1
New Carnitine salts particularly suitable for oral use
EP0207436A2
New cytidine-diphosphocholine salts, particularly suitable for oral use
EP0184248A2
Salts of 5'-methylthio-5'-deoxyadenosine with long-alkyl chain sulphonic acids
IT8521446D0
Anti-amnesia cpds.
JPS60255735A
Pharmaceutical composition comprising sulfo-adenosyl-l-methionine(same) salt, particularly for oral and suppository drug
EP0162324A1
Stable sulpho+adenosyl-l-methionine (same) salts, particularly suitable for oral pharmaceutical use
EP0141914A1
Process for producing stable S-adenosyl-L-methionine salts
EP0136464A2
Therapeutic compositions for oral use containing stable S-Adenosy1-L-Methionine salts
